PWMG
SRTA

Prestige Wealth Management Group’s Strata Critical Medical Inc SRTA Stock Holding History

Prestige Wealth Management Group’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.12K Hold
1,225
– – ﹤0.01% 551
2025
Q4 		$5.89K Hold
1,225
– – ﹤0.01% 537
2025
Q3 		$6.2K Hold
1,225
– – ﹤0.01% 530
2025
Q2 		$4.94K Buy
+1,225
New +$3.99K ﹤0.01% 564

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prestige Wealth Management Group's SRTA Position: Q1 2026 in Review

Prestige Wealth Management Group held its Strata Critical Medical Inc (SRTA) position steady in Q1 2026 at 1,225 shares worth $5.12K. The position accounts for ﹤0.01% of the portfolio, ranked #551.

Prestige Wealth Management Group first reported a position in SRTA in Q2 2025 and has held it in 4 quarters since. The position peaked at $6.2K in Q3 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Prestige Wealth Management Group held 1,225 shares of Strata Critical Medical Inc worth $5.12K as of Q1 2026.
  • Prestige Wealth Management Group left its Strata Critical Medical Inc share count unchanged in Q1 2026.
  • Strata Critical Medical Inc made up ﹤0.01% of Prestige Wealth Management Group's portfolio in Q1 2026, its #551 holding.
  • Prestige Wealth Management Group first reported a position in Strata Critical Medical Inc in Q2 2025 and has held it in 4 quarters since.
  • Prestige Wealth Management Group's Strata Critical Medical Inc position peaked at $6.2K in Q3 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Prestige Wealth Management Group's 13F filing for Q1 2026, filed 13 May 2026.